Federal Register / Vol. 72, No.
41 / Friday, March 2, 2007 / Notices 9545
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 23, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–962 Filed 3–1–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information oncerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; In Vitro Testing Resources
for AIDS Therapeutics Development.
Date: March 16, 2007.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Holiday Inn Chevy Chase, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Barney Duane Price, PhD,
Scientific Review Administrator, Scientific
Review Program, DHHS/NIH/NIAID/DEA,
Room 3139, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892–7616, (301) 451–
2592, pricebd@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 23, 2007.
pwalker on PROD1PC71 with NOTICES
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–963 Filed 3–1–07; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005 19:22 Mar 01, 2007 Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Minority Biomedical Research
Support.
Date: March 16, 2007.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Hotel, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Helen R. Sunshine, PhD,
Chief, Office of Scientific Review, National
Institute of General Medical Sciences,
National Institutes of Health, Natcher
Building, Room 3AN12F, Bethesda, MD
20892. 301–594–2881.
sunshinh@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: February 22, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–969 Filed 3–1–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\02MRN1.SGM
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Pathway to Independence Award.
Date: March 21, 2007.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator, Office
of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Blvd., Bethesda, MD
20892–8401, (301) 402–6626,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Field-
Deployable Tools Review Panel.
Date: March 22, 2007.
Time: 9 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Omni Shoreham Hotel of
Washington DC, 2500 Calvert Street, NW., (at
Connecticut Avenue), Washington, DC
20008.
Contact Person: Mark Swieter, PhD, Chief,
Training and Special Projects Review Branch,
Office of Extramural Affairs, National
Institute on Drug Abuse, NIH, DHHS, 6101
Executive Boulevard, Suite 220, Bethesda,
MD 20892–8401, (301) 435–1389,
ms80x@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 23, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–972 Filed 2–22–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
02MRN1
 9546 Federal Register / Vol. 72, No. 41 / Friday, March 2, 2007 / Notices
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the Board
of Regents of the National Library of
Medicine.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Regents of
the National Library of Medicine; Extramural
Programs Subcommittee.
Date: May 7, 2007.
Closed: 4 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, Conference Room B, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Donald A.B. Lindberg, MD,
Director, National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20894, 301–
496–6221, lindberg@mail.nih.gov.
Name of Committee: Board of Regents of
the National Library of Medicine;
Subcommittee on Outreach and Public
Information.
Date: May 8, 2007.
Open: 7:30 a.m. to 8:45 a.m.
Agenda: Outreach Activities.
Place: National Library of Medicine,
Building 38, Conference Room B, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Donald A.B. Lindberg, MD,
Director, National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20894, 301–
496–6221, lindberg@mail.nih.gov.
Name of Committee: Board of Regents of
the National Library of Medicine.
Date: May 8–9, 2007.
Open: May 8, 2007, 9 a.m. to 4:30 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20892.
Closed: May 8, 2007, 4:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
pwalker on PROD1PC71 with NOTICES
Rockville Pike, Bethesda, MD 20892.
Open: May 9, 2007, 9 a.m. to 12 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville, Pike, Bethesda, MD 20892.
VerDate Aug<31>2005 18:44 Mar 01, 2007 Jkt 211001
Contact Person: Donald A.B. Lindberg, MD,
Director, National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20894, 301–
496– 6221, lindberg@mail.nih.gov.
Name of Committee: Board of Regents of
the National Library of Medicine Planning
Subcommittee.
Date: May 9, 2007.
Open: 7:30 a.m. to 8:45 a.m.
Agenda: Long-Range Planning Discussion.
Place: National Library of Medicine,
Building 38, Conference Room B, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Donald A.B. Lindberg, MD,
Director, National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20894, 301–
496–6221, lindberg@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.nlm.nih.gov/od/bor/bor.html, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: February 23, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–971 Filed 3–1–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Toxicology Program (NTP);
Liaison and Scientific Review Office;
Meeting of the NTP Board of Scientific
Counselors Technical Reports Review
Subcommittee
AGENCY: National Institute of
Environmental Health Sciences
(NIEHS), National Institutes of Health
(NIH).
ACTION: Meeting announcement and
request for comments.
SUMMARY: Pursuant to Public Law 92–
463, notice is hereby given of a meeting
of the NTP Board of Scientific
Counselors Technical Reports Review
PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\02MRN1.SGM
Subcommittee (TRR Subcommittee).
The primary agenda topic is the peer
review of the findings and conclusions
presented in eight draft NTP Technical
Reports of rodent toxicology and
carcinogenicity studies in rats and mice
conducted by the NTP (see Preliminary
Agenda below). The TRR Subcommittee
meeting is open to the public with time
scheduled for oral public comment. The
NTP also invites written comments on
any draft technical report discussed at
the meeting (see Request for Comments,
below). The TRR Subcommittee
deliberations on the draft technical
reports will be reported to the NTP
Board of Scientific Counselors (BSC) at
a future date.
DATES: The TRR Subcommittee meeting
will be held on May 16 and 17, 2007.
All individuals who plan to attend are
encouraged to register online by May 9,
2007, at the NTP Web site (http://
ntp.niehs.nih.gov/ select ‘‘Calendar of
Upcoming Events’’). Written comments
on the draft reports should be received
by May 2, 2007. Persons needing special
assistance, such as sign language
interpretation or other reasonable
accommodation in order to attend,
should contact 919–541–2475 (voice),
919–541–4644 TTY (text telephone),
through the Federal TTY Relay System
at 800–877–8339, or by e-mail to
niehsoeeo@niehs.nih.gov. Requests
should be made at least 7 days in
advance of the event.
ADDRESSES: The TRR Subcommittee
meeting will be held in the Rodbell
Auditorium, Rall Building at the NIEHS,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709. Public
comments and any other
correspondence should be submitted to
Dr. Barbara Shane, Executive Secretary
for the NTP Board (NTP Liaison and
Scientific Review Office, NIEHS, P.O.
Box 12233, MD A3–01, Research
Triangle Park, NC 27709; telephone:
919–541–4253, fax: 919–541–0295; or e-
mail: shane@niehs.nih.gov).
SUPPLEMENTARY INFORMATION:
Background
The primary agenda topic is the peer
review of the findings and conclusions
of eight draft NTP Technical Reports of
rodent toxicology and carcinogenicity
studies conducted by the NTP (see
Preliminary Agenda below) in rats and
mice.
Attendance and Registration
The meeting is scheduled for May 16–
17, 2007, from 8:30 a.m. to adjournment
and is open to the public with
attendance limited only by the space
available. Individuals who plan to
02MRN1